Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. In 2007, the warning was expanded to include young adults aged under 25 years....
Main Authors: | Martin Whitely, Melissa Raven, Jon Jureidini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00478/full |
Similar Items
-
Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
by: Glen I. Spielmans, et al.
Published: (2020-02-01) -
Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified
by: Wayne K. Goodman, et al.
Published: (2020-04-01) -
The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
by: Michele Fornaro, et al.
Published: (2019-05-01) -
Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm
by: Michael P. Hengartner
Published: (2017-12-01) -
Antidepressants and Suicide Risk: A Comprehensive Overview
by: Roberto Tatarelli, et al.
Published: (2010-08-01)